CFTR and cystic fibrosis: Ischemic pre-conditioning reduced the rate of CF-to-MF differentiation in rats; a protective mechanism that was recapitulated by treatment of cells with the mKATP activator diazoxide, but not pinacidil, and was abolished by treatment of CF with the KATP inhibitor glibenclamide [262].